Atea Pharmaceuticals, Inc. Current Liabilities
Atea Pharmaceuticals, Inc. (AVIR) had Current Liabilities of $28.12 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $28.12M.
- 2026-03-31: Liabilities, Current $33.37M.
- 2025-12-31: Liabilities, Current $39.78M.
- 2025-09-30: Liabilities, Current $20.18M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $28.12M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $33.37M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $39.78M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $20.18M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $20.12M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $21.75M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $18.60M 10-K · filed 2026-03-05 |
| 2024-09-30 | $25.19M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $26.62M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $41.31M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $32.38M 10-K · filed 2025-03-06 |
| 2023-09-30 | $18.89M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $16.16M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $12.36M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $18.48M 10-K · filed 2024-02-28 |
| 2022-09-30 | $15.63M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $25.11M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $28.61M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $56.88M 10-K · filed 2023-02-28 |
| 2021-09-30 | $262.05M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $273.65M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $254.28M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $315.80M 10-K · filed 2022-02-28 |
| 2020-09-30 | $10.82M 10-Q · filed 2020-12-10 |
| 2019-12-31 | $2.44M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |